These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38362350)

  • 1. The Antioxidant/Nitric Oxide-Quenching Agent Cobinamide Prevents Aortic Disease in a Mouse Model of Marfan Syndrome.
    Kalyanaraman H; Casteel DE; Cabriales JA; Tat J; Zhuang S; Chan A; Dretchen KL; Boss GR; Pilz RB
    JACC Basic Transl Sci; 2024 Jan; 9(1):46-62. PubMed ID: 38362350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitro-oleic acid reduces thoracic aortic aneurysm progression in a mouse model of Marfan syndrome.
    Nettersheim FS; Lemties J; Braumann S; Geißen S; Bokredenghel S; Nies R; Hof A; Winkels H; Freeman BA; Klinke A; Rudolph V; Baldus S; Mehrkens D; Mollenhauer M; Adam M
    Cardiovasc Res; 2022 Jul; 118(9):2211-2225. PubMed ID: 34324651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aortic pathology from protein kinase G activation is prevented by an antioxidant vitamin B
    Schwaerzer GK; Kalyanaraman H; Casteel DE; Dalton ND; Gu Y; Lee S; Zhuang S; Wahwah N; Schilling JM; Patel HH; Zhang Q; Makino A; Milewicz DM; Peterson KL; Boss GR; Pilz RB
    Nat Commun; 2019 Aug; 10(1):3533. PubMed ID: 31387997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Antioxidant Vitamin B12 Analogue Cobinamide as a Treatment for Marfan Syndrome.
    Wagner AH
    JACC Basic Transl Sci; 2024 Jan; 9(1):63-64. PubMed ID: 38362344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pravastatin reduces Marfan aortic dilation.
    McLoughlin D; McGuinness J; Byrne J; Terzo E; Huuskonen V; McAllister H; Black A; Kearney S; Kay E; Hill AD; Dietz HC; Redmond JM
    Circulation; 2011 Sep; 124(11 Suppl):S168-73. PubMed ID: 21911808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of AT1a (Angiotensin II Type 1a) Receptor or Inhibition of Angiotensinogen Synthesis Attenuates Thoracic Aortopathies in Fibrillin1
    Chen JZ; Sawada H; Ye D; Katsumata Y; Kukida M; Ohno-Urabe S; Moorleghen JJ; Franklin MK; Howatt DA; Sheppard MB; Mullick AE; Lu HS; Daugherty A
    Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2538-2550. PubMed ID: 34407634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-6 regulates extracellular matrix remodeling associated with aortic dilation in a fibrillin-1 hypomorphic mgR/mgR mouse model of severe Marfan syndrome.
    Ju X; Ijaz T; Sun H; Lejeune W; Vargas G; Shilagard T; Recinos A; Milewicz DM; Brasier AR; Tilton RG
    J Am Heart Assoc; 2014 Jan; 3(1):e000476. PubMed ID: 24449804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox stress in Marfan syndrome: Dissecting the role of the NADPH oxidase NOX4 in aortic aneurysm.
    Jiménez-Altayó F; Meirelles T; Crosas-Molist E; Sorolla MA; Del Blanco DG; López-Luque J; Mas-Stachurska A; Siegert AM; Bonorino F; Barberà L; García C; Condom E; Sitges M; Rodríguez-Pascual F; Laurindo F; Schröder K; Ros J; Fabregat I; Egea G
    Free Radic Biol Med; 2018 Apr; 118():44-58. PubMed ID: 29471108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced caspase activity contributes to aortic wall remodeling and early aneurysm development in a murine model of Marfan syndrome.
    Emrich FC; Okamura H; Dalal AR; Penov K; Merk DR; Raaz U; Hennigs JK; Chin JT; Miller MO; Pedroza AJ; Craig JK; Koyano TK; Blankenberg FG; Connolly AJ; Mohr FW; Alvira CM; Rabinovitch M; Fischbein MP
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):146-54. PubMed ID: 25359856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitive detection of abnormal aortic architecture in Marfan syndrome with high-frequency ultrasonic tissue characterization.
    Recchia D; Sharkey AM; Bosner MS; Kouchoukos NT; Wickline SA
    Circulation; 1995 Feb; 91(4):1036-43. PubMed ID: 7850939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aortic disease in Marfan syndrome is caused by overactivation of sGC-PRKG signaling by NO.
    de la Fuente-Alonso A; Toral M; Alfayate A; Ruiz-Rodríguez MJ; Bonzón-Kulichenko E; Teixido-Tura G; Martínez-Martínez S; Méndez-Olivares MJ; López-Maderuelo D; González-Valdés I; Garcia-Izquierdo E; Mingo S; Martín CE; Muiño-Mosquera L; De Backer J; Nistal JF; Forteza A; Evangelista A; Vázquez J; Campanero MR; Redondo JM
    Nat Commun; 2021 May; 12(1):2628. PubMed ID: 33976159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor β Signaling.
    Wei H; Hu JH; Angelov SN; Fox K; Yan J; Enstrom R; Smith A; Dichek DA
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28119285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disturbed nitric oxide signalling gives rise to congenital bicuspid aortic valve and aortopathy.
    Peterson JC; Wisse LJ; Wirokromo V; van Herwaarden T; Smits AM; Gittenberger-de Groot AC; Goumans MTH; VanMunsteren JC; Jongbloed MRM; DeRuiter MC
    Dis Model Mech; 2020 Sep; 13(9):. PubMed ID: 32801116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide in the Marfan vasculature: Friend or foe?
    Tehrani AY; Ciufolini MA; Bernatchez P
    Nitric Oxide; 2021 Nov; 116():27-34. PubMed ID: 34478846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-29b participates in early aneurysm development in Marfan syndrome.
    Merk DR; Chin JT; Dake BA; Maegdefessel L; Miller MO; Kimura N; Tsao PS; Iosef C; Berry GJ; Mohr FW; Spin JM; Alvira CM; Robbins RC; Fischbein MP
    Circ Res; 2012 Jan; 110(2):312-24. PubMed ID: 22116819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol Inhibits Aortic Root Dilatation in the Fbn1C1039G/+ Marfan Mouse Model.
    Hibender S; Franken R; van Roomen C; Ter Braake A; van der Made I; Schermer EE; Gunst Q; van den Hoff MJ; Lutgens E; Pinto YM; Groenink M; Zwinderman AH; Mulder BJ; de Vries CJ; de Waard V
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1618-26. PubMed ID: 27283746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular smooth muscle cell phenotypic changes in patients with Marfan syndrome.
    Crosas-Molist E; Meirelles T; López-Luque J; Serra-Peinado C; Selva J; Caja L; Gorbenko Del Blanco D; Uriarte JJ; Bertran E; Mendizábal Y; Hernández V; García-Calero C; Busnadiego O; Condom E; Toral D; Castellà M; Forteza A; Navajas D; Sarri E; Rodríguez-Pascual F; Dietz HC; Fabregat I; Egea G
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):960-72. PubMed ID: 25593132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age and sex dependency of thoracic aortopathy in a mouse model of Marfan syndrome.
    Gharraee N; Sun Y; Swisher JA; Lessner SM
    Am J Physiol Heart Circ Physiol; 2022 Jan; 322(1):H44-H56. PubMed ID: 34714692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of elastin deficit in a Marfan mouse aneurysm model using an elastin-specific magnetic resonance imaging contrast agent.
    Okamura H; Pisani LJ; Dalal AR; Emrich F; Dake BA; Arakawa M; Onthank DC; Cesati RR; Robinson SP; Milanesi M; Kotek G; Smit H; Connolly AJ; Adachi H; McConnell MV; Fischbein MP
    Circ Cardiovasc Imaging; 2014 Jul; 7(4):690-6. PubMed ID: 24814820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the Thoracic Aorta by Region and Sex in a Murine Model of Marfan Syndrome.
    Jiménez-Altayó F; Siegert AM; Bonorino F; Meirelles T; Barberà L; Dantas AP; Vila E; Egea G
    Front Physiol; 2017; 8():933. PubMed ID: 29187826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.